HERON THERAPEUTICS, INC. /DE/ Depreciation
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Depreciation of $1.50 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2019-02-22
- HERON THERAPEUTICS, INC. /DE/ depreciation for fiscal 2018 was $1.50M, a 0.00% change from fiscal 2017.
- HERON THERAPEUTICS, INC. /DE/ depreciation for fiscal 2017 was $1.50M, a 36.36% increase from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ depreciation for fiscal 2016 was $1.10M, a 57.14% increase from fiscal 2015.
- HERON THERAPEUTICS, INC. /DE/ depreciation for fiscal 2015 was $700.00K, a 16.67% increase from fiscal 2014.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2018-12-31 | $1.50M 10-K · filed 2019-02-22 | |
| 2017-12-31 | $1.50M 10-K · filed 2019-02-22 | |
| 2016-12-31 | $1.10M 10-K · filed 2019-02-22 | |
| 2015-12-31 | $700.00K 10-K · filed 2018-02-27 | $734.00K 10-K · filed 2016-02-19 |
| 2014-12-31 | $600.00K 10-K · filed 2017-02-23 | $578.00K 10-K · filed 2015-03-13 |
| 2013-12-31 | $333.00K 10-K · filed 2016-02-19 | |
| 2012-12-31 | $197.00K 10-K · filed 2015-03-13 | |
| 2011-12-31 | $179.00K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |